Lewis & Clark Pharmaceuticals focuses on early-stage pharmaceutical development for addressing the areas of arthritis, diabetes, glaucoma, and atherosclerosis.
The company was incorporated in 2012 by Robert Thompson and is based in Charlottesville, Virginia.